CLEVELAND, May 06, 2022 (GLOBE NEWSWIRE) — SPR Therapeutics announced the publication of a study that evaluated the real-world impact of 60-day peripheral nerve stimulation (PNS) in the management of chronic pain. To investigate if this short-term treatment could provide long-term relief in a real-world setting, a cross-sectional survey was conducted of patients who had […]
HistoSonics Receives FDA “Breakthrough Device Designation” for Novel Sonic Beam Therapy Abilitech Medical Raises $2.9M to Expand Exoskeleton Technology SPR Therapeutics Scores $37M for Pain Relief Tool and Other Digital Health Fundings Washington’s Proliance Surgeons and Minnesota’s Revo Health Strike Blockbuster Partnership Nuwellis Selected as a Recipient of the Governor’s International Trade Award Women in […]
CLEVELAND, Ohio (Oct. 19, 2021) – SPR Therapeutics® has obtained clearance from the U.S. Food and Drug Administration (FDA) of a broader indication for use for its SPRINT Peripheral Nerve Stimulation (PNS) System. Prior clearance limited use of the SPRINT PNS System to the back and extremities, but the new indication allows the device to be used […]
Cleveland, Ohio (October 18, 2021) – SPR Therapeutics, a private medical device company focused on providing patients with pain relief without opioids or surgery, announced today it has raised $37 million in an oversubscribed Series D growth equity financing. The investment will be used to accelerate the rapidly growing commercial uptake of its FDA-cleared SPRINT® Peripheral Nerve […]
CLEVELAND, July 12, 2021 – In the largest, most rigorous study to date using the SPRINT® PNS System for chronic axial low back pain (LBP), patients that failed to find relief from at least two different prior LBP treatments (e.g., opioids, over-the-counter analgesics, physical therapy), were treated with the SPRINT PNS System targeting the lumbar medial […]
Mark has been actively involved in health care and medical device market development for over 25 years, having held senior positions at both large and emerging medical device companies spanning multiple disease states and technologies. Much of Mark’s past work has involved global market development for implantable product lines, with nearly 20 years spent specifically […]
Cleveland, Ohio- April 26, 2021- Results of a multicenter trial recently published in Anesthesiology, the official peer-reviewed journal of the American Society of Anesthesiologists,demonstrated significant reductions in postoperative opioid use and pain following percutaneous peripheral nerve stimulation (PNS) compared to placebo. Participants undergoing painful orthopedic surgical procedures such as rotator cuff repair were randomized to receive PNS […]
Stimulation of peripheral nerves warrants consideration early in the care continuum. Cleveland, Ohio- March 15, 2021- A novel theory recently published in the Journal of Pain Research proposes mechanisms by which a 60-day treatment using percutaneous peripheral nerve stimulation (PNS) may recondition the central nervous system (CNS) to restore normal pain processing and provide long-term pain relief for […]
CLEVELAND, March 02, 2021 — SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced publication of clinical data evaluating the impact of percutaneous peripheral nerve stimulation (PNS) for patients with recurrent low back pain who underwent a radiofrequency ablation (RFA) procedure at least six months prior. The study, published in Pain Medicine, evaluated patients who […]
Kindeva Appoints Shawn Cavanagh to Board of Directors SPR Therapeutics, Inc. Appoints Josh Boggs, PhD, As Chief Scientific Officer Smiths Medical Announces Launch of Portex® EchoGlo® Peripheral Nerve Block Portfolio Humanetics Corporation Receives Funding From Department of Defense to Test Drug Against COVID-19 Celcuity Announces Breast Cancer Clinical Trial Collaboration with Sarah Cannon and Pfizer […]